From WikiMD

Information about Lixisenatide

Lixisenatide is a recombinant DNA produced polypeptide analogue of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents.

Liver safety of Lixisenatide

Therapy with lixisenatide has not been associated with serum enzyme elevations or with episodes of clinically apparent liver injury.

Mechanism of action of Lixisenatide

Lixisenatide (lix" i sen' a tide) is a glucagon-like peptide-1 (GLP-1) analogue (also called a GLP-1 receptor agonist) that acts like the native gastrointestinal hormone (incretin) to increase insulin secretion. Lixisenatide, like other GLP-1 analogues, also suppress glucagon production and slows gastric emptying, features that may increase the beneficial effects in type 2 diabetes. Lixisenatide is a recombinant DNA-produced polypeptide that is 44 amino acids in length with a single proline substitution and a modified C-terminus of six lysine molecules that makes it relatively resistant to degradation by dipeptidyl peptidase 4 (DPP4) and extends its half-life allowing for once daily dosing. In multiple preregistration clinical trials, lixisenatide was shown to improve glycemic control and lower HbA1c levels in patients with inadequately controlled type 2 diabetes.

FDA approval information for Lixisenatide

Lixisenatide was approved in the United States in 2016 and current indications are for management of glycemic control in adults with type 2 diabetes in combination with diet and exercise, with or without other oral hypoglycemic agents or insulin.

Brand name for Lixisenatide

Lixisenatide is available under the brand name Adlyxin in multiuse prefilled pens (50 and 100 µg/mL).

Dosage and administration for Lixisenatide

The recommended starting dose is 10 µg once daily which after 2 weeks can be increased to 20 µg once daily. A fixed combination of lixisenatide (33 µg/mL) with insulin glargine (100 units/mL) is also available under the brand name Soliqua (100/33).

Side effects of Lixisenatide

Lixisenatide is generally well tolerated, but side effects can be dose limiting and include injection site reactions, diarrhea, nausea, vomiting, dizziness, headache, fatigue and hypoglycemia. Rare adverse events include pancreatitis, severe hypoglycemia, acute renal injury and hypersensitivity reactions.


Cost and Coupons - Lixisenatide

Reviews for Lixisenatide

The article on Lixisenatide is a stub. YOU can help Wikimd by expanding it!

Medication resources

Learn more


WikiMD Resources - Lixisenatide

Help WikiMD:Join WikiMD as an an editor and help improve the page Lixisenatide or others.
W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's insurance Weight loss program can HELP*

Quick links: Medicine Portal | Encyclopedia‏‎‏‎ | Gray's Anatomy‏‎ | Topics‏‎ |‏‎ Diseases‏‎ | Drugs | Wellness | Obesity‏‎ | Metabolic syndrome | Weight loss*
Disclaimer: The entire contents of WIKIMD.ORG are for informational purposes only and do not render medical advice or professional services. If you have a medical emergency, you should CALL 911 immediately! Given the nature of the wiki, the information provided may not be accurate, misleading and or incorrect. Use the information on this wiki at your own risk! See full Disclaimer.
Link to this page: <a href="">Lixisenatide</a>

  • Individual results may vary for weight loss from our sponsors.